Search results:
General Information
| Gene_Symbol | Gene_ID | Gene_Name | Chromosome | Alias |
|---|---|---|---|---|
| SLC2A1 | 6513 | Solute carrier family 2 (facilitated glucose transporter), member 1  | 1 | PED; DYT9; GLUT; DYT17; DYT18; EIG12; GLUT1; HTLVR; GLUT1DS  |
- Evidence
- Gene
- mRNA
- CDS
- Protein
- PTM
- Enzyme
- PPi
- Pathway
- Structural
- Domain
- Ontology
- SNP
- Drug
- External Links
Evidence Information
| Pubmed ID | Year | Sample Information | Techniques | Mechanism | Fold Change | Remark |
|---|---|---|---|---|---|---|
| 18097579    | 2005 | Cell line : - Source : - Sample Type : CRC tumor and normal tissue No. of Sample : 60 specimens of colorectal adenocarcinoma and 20 specimens of normal colorectal tissues Stage : - | Immunohistochemistry | Up-regulation | - | The overexpressions of Glut1 and HIF-1alpha play important roles in carcinogenesis and progression of colorectal adenocarcinoma, and closely correlate with cell proliferation of colorectal adenocarcinoma. Positive rates of Glut1 and HIF-1alpha were significantly higher in colorectal adenocarcinoma tissues than in normal colorectal tissues . |
| 19619276    | 2009 | Cell line : SW 620, SW 480 Source : - Sample Type : CRC tumor and normal tissue, Blood sample No. of Sample : 10 Stage : - | RT-PCR | Up-regulation | - | GLUT1 has the potential to be employed as a molecular marker to indicate the degree of hypoxia experienced by tumors circulating in the blood of cancer patients.
The increased relative expression ratio of GLUT1 mRNA, under hypoxic conditions was higher in SW620 cells than in SW480 cells. |
| 21786248    | 2011 | Cell line : - Source : - Sample Type : CRC tumor and normal tissue, Blood sample No. of Sample : 163 primary tumors together ,36 liver metastases. Stage : TNM Stage I-IV | RT-PCR | Up-regulation | - | Overexpression of GLUT1 in stage I-III CRCs was independently associated with poor prognosis. The expression of GLUT1 in 163 primary tumors together with the corresponding normal mucosa, and 36 liver metastases was examined using real-time PCR. In CRCs, GLUT1 expression was higher in poorly differentiated than in well and moderately differentiated tumors and higher in stage III IV than in stage I II tumors. |
| 22282467    | 2012 | Cell line : - Source : Kyoto University Hospital Sample Type : CRC tumor and normal tissue, Blood sample No. of Sample : 63 CRC patients Stage : - | PET imaging and analysis, Immunohistochemical analysis. | Up-regulation | - | GLUT1 expression in cancer cells was positively correlated with FDG accumulation and KRAS/BRAF status. |
| 22968445    | 2012 | Cell line : - Source : Department of Pathology of Wrocaw Medical University. Sample Type : - No. of Sample : Samples of grade 2 of CRC Stage : - | Laser capture microdissection,FFPE-FASP,SAX fractionation,LC-MSMS,Label-free quantitation | Up-regulation | 20 | - |
Gene Details

| Gene Type | protein coding |
|---|---|
| Gene Family | Solute carriers |
| Description | This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia. [provided by RefSeq, Apr 2013]   | Chromosome | 1 |
| Location | 1p34.2 |
| Start | 42925375   |
| End | 42959176   |
| Strand | -   |
| Gene Sequence |    Download   Select all |
| Length | 33802   |
| OMIM ID | 138140    |
| HGNC ID | HGNC:11005    |
| Unigene ID | Hs.473721     |
| Ensembl ID | ENSG00000117394    |
| PharmGKB ID | -    |
mRNA Information
| mRNA ID | NM_006516.2 |
|---|---|
| Exon | join(1..543,15856..15951,27971..28131,28311..28551, 29142..29304,29397..29584,29863..29967,30144..30245, 31369..31572,31936..33802)   | mRNA Sequence |    Download   Select all |
| Length | 3687   |
CDS Information
| Location | join(526..543,15856..15951,27971..28131,28311..28551, 29142..29304,29397..29584,29863..29967,30144..30245, 31369..31572,31936..32136) |
|---|---|
| CDS Sequence |    Download   Select all |
| CCDS ID | CCDS477.1 |    
Protein Information
| Protein ID | NP_006507.2 |
|---|---|
| Protein Name | Solute carrier family 2 (facilitated glucose transporter), member 1 |
| Molecular Wt. (Da) | 53953 |
| Protein Sequence |    Download   Select all |
| Length | 492   |
| Uniprot ID | P11511 |    
| Ensembl Protein ID | ENSP00000260433   |    
Post-translational Modification Information (Source : HPRD)
| Residue | Type | site |
|---|---|---|
| N | Glycosylation | 45 |
| S | Phosphorylation | 490;- |
| S | Phosphorylation | 473 |
| S | Phosphorylation | 465 |
| T | Phosphorylation | 478 |
| S | Phosphorylation | 118 |
Enzyme Information
No matching records could be found.
PPi Information
(Click to view network : Source STRING)      View   
| Interactant Gene ID (Source: HPRD) | Gene Symbol | HPRD ID | Ref Seq ID | Technique | References |
|---|---|---|---|---|---|
| 811 |    CALR |    169 |    NP_004334.1 |    in vivo |    8662691    |
| 821 |    CANX |    252 |    NP_001737.1 |    in vivo |    8662691    |
| 2040 |    STOM |    585 |    NP_004090.4 |    in vitro;in vivo |    10562431    |
| 10980 |    COPS6 |    16735 |    NP_006824.2 |    yeast 2-hybrid |    16169070    |
Pathway Information
| Pathway Name | Pathway ID |
|---|---|
| Adipocytokine signaling pathway |    hsa04920 |    
| Bile secretion |    hsa04976 |    
| Central carbon metabolism in cancer |    hsa05230 |    
| Glucagon signaling pathway |    hsa04922 |    
| HIF-1 signaling pathway |    hsa04066 |    
| HTLV-I infection |    hsa05166 |    
| Insulin resistance |    hsa04931 |    
| Insulin secretion |    hsa04911 |    
| Pathways in cancer |    hsa05200 |    
| Renal cell carcinoma |    hsa05211 |    
| Thyroid hormone signaling pathway |    hsa04919 |    
Structure Information
No matching records could be found.
Domain Information
| ID | Location | Description |
|---|---|---|
| cd06174 | 62-450  | MFS |
| cl21472 | 62-450  | MFS superfamily |
| TIGR00880 | 66-206  | 2_A_01_02 |
| cd06174 | 66-208  | MFS |
| pfam00083 | 19-467  | Sugar_tr |
| TIGR00879 | 19-463  | SP |
| PRK10077 | 19-463  | xylE |
| TIGR00898 | 50-462  | 2A0119 |
| TIGR00883 | 67-407  | 2A0106 |
| pfam07690 | 66-417  | MFS_1 |
| TIGR00895 | 65-245  | 2A0115 |
| TIGR01299 | 71-234  | synapt_SV2 |
| TIGR00887 | 73-464  | 2A0109 |
| TIGR00893 | 66-449  | 2A0114 |
| TIGR00891 | 57-410  | 2A0112 |
| COG2814 | 67-176  | AraJ |
| TIGR00891 | 54-169  | 2A0112 |
| pfam07690 | 66-171  | MFS_1 |
| COG0477 | 52-372  | ProP |
| pfam13347 | 64-147  | MFS_2 |
| TIGR00883 | 57-155  | 2A0106 |
| pfam13347 | 245-410  | MFS_2 |
Ontology Information
| HPRD ID | 3139 |    
|---|---|
| Molecular Class | Membrane transport protein |
| Molecular Function | Receptor signaling complex scaffold activity (GO:0030159) |
| Biological Process | Cell communication (GO:0007154); Signal transduction (GO:0007165)   |
Drug Information
| Uniprot ID | DrugBank ID | Name | Type |
|---|---|---|---|
| P11166 | DB00292 | Etomidate | SmallMoleculeDrug |
External Links
| ArrayExpress | GO |    
|---|---|
| ICGC | GO |    
| Cancer3D | GO |    
| COSMIC | GO |    
| NCG | GO |    
| TSGene | GO |    
| Tumor Gene Family of Databases | GO |    
| CCDB | GO |    
| G2SBC | GO |    
| Osteosarcoma Database | GO |    
| RCDB | GO |    
